B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for High-Risk leukemia: phase 2 trial of recombinant erwinia asparaginase launches
Disease control Recruiting nowThis study tests a new version of the chemotherapy drug asparaginase (made from Erwinia bacteria) in adults aged 18–54 with high-risk acute lymphoblastic leukemia or lymphoblastic lymphoma. The drug is given alongside standard chemotherapy to see if it is safe and effective. Abou…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
New combo therapy shows promise for tough leukemia
Disease control Recruiting nowThis study is for adults with acute lymphoblastic leukemia (ALL), including those over 60 or unfit for standard chemo. It combines a targeted antibody-drug (inotuzumab ozogamicin) with low-intensity chemotherapy to kill cancer cells while reducing side effects. The goal is to fin…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC